Volume | 296,278 |
|
|||||
News | (1) | ||||||
Day High | 15.03 | Low High |
|||||
Day Low | 14.71 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Bausch plus Lomb Corporation | BLCO | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
15.03 | 14.71 | 15.03 | 14.74 | 14.94 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
3,873 | 296,278 | $ 14.89 | $ 4,412,568 | - | 13.16 - 21.95 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:00:00 | 22,134 | $ 14.74 | USD |
Bausch plus Lomb Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
7.1B | 350.99M | - | 4.15B | -260M | -0.74 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Bausch plus Lomb News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BLCO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 14.85 | 15.23 | 14.66 | 14.94 | 197,538 | -0.11 | -0.74% |
1 Month | 14.58 | 15.72 | 14.45 | 15.10 | 244,279 | 0.16 | 1.10% |
3 Months | 16.61 | 17.525 | 13.16 | 14.89 | 462,521 | -1.87 | -11.26% |
6 Months | 15.45 | 17.695 | 13.16 | 15.29 | 461,652 | -0.71 | -4.60% |
1 Year | 19.50 | 21.95 | 13.16 | 16.44 | 475,593 | -4.76 | -24.41% |
3 Years | 18.50 | 21.95 | 12.20 | 16.36 | 604,915 | -3.76 | -20.32% |
5 Years | 18.50 | 21.95 | 12.20 | 16.36 | 604,915 | -3.76 | -20.32% |
Bausch plus Lomb Description
Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries. |